Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics
Cancers have a high mortality rate due to lack of suitable specific early diagnosis tumor biomarkers. Emerging evidence is accumulating that lncRNAs (long noncoding RNAs) are involved in tumorigenesis, tumor cells proliferation, invasion, migration, apoptosis, and angiogenesis. Furthermore, extracel...
Main Authors: | Ting Shi, Ge Gao, Yingli Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2016/9085195 |
Similar Items
-
Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer
by: Jia-jun Wang, et al.
Published: (2019-01-01) -
Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer
by: Yu-Hui Wang, et al.
Published: (2018-03-01) -
Diagnostic and Prognostic Value of Long Noncoding RNAs as Potential Novel Biomarkers in Intrahepatic Cholestasis of Pregnancy
by: Shaohan Zou, et al.
Published: (2021-01-01) -
Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma.
by: Johanna Droop, et al.
Published: (2017-01-01) -
Long Noncoding RNAs as Biomarkers in Cancer
by: Luka Bolha, et al.
Published: (2017-01-01)